Director, Research & Investments
and access,
Yassine Bensaada is a Senior Analyst on the Investment Team at DRI Healthcare. Yassine has over 3 years of industry experience within the life sciences across Business Development, Commercial Operations, and Business Intelligence functions. Prior to joining DRI Healthcare, Yassine spent 3 years with Purdue Pharma (Canada)/Elvium Life Sciences, a commercial-stage Canadian life sciences company with a focus in Neurosciences, Cancer-Supportive Care, and Consumer Health. Yassine graduated from the Master’s in Biotechnology (MBiotech) program at University of Toronto and completed his Undergraduate degree in Neurosciences from the University of Calgary. He is currently pursuing his CFA Level 2 designation.
